Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH) [PDF]
, 2020 Jörn M. Schattenberg
openalex +1 more source
Hepatology Research, EarlyView.Three metabolites, pyroglutamylglycine (pyroGluGly), phenylalanine (Phe), and phenylalanyltryptophan (PheTrp), were identified as candidate DILI biomarkers. The serum concentrations of pyroGluGly, Phe, and PheTrp demonstrated a high differentiating ability in patients with mixed and cholestatic DILI compared with those in patients who recovered from ...
Kosuke Saito +22 more
wiley +1 more source
NASH IN CHILDREN – A SHORT REVIEW
Khyber Medical University Journal, 2010 Nonalcoholic fatty liver disease (NAFLD) describes a hepatic disorder with the typical characteristics of an alcoholic liver disease without alcohol consumption.
M Fazal Karim +3 more
doaj
Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis [PDF]
, 2007 Kanji Yamaguchi +9 more
openalex +1 more source
Journal of Gastroenterology and Hepatology, EarlyView.ABSTRACT Background and Aims People of South Asian ethnicities are at increased risk of metabolic syndrome, but the epidemiology of metabolic dysfunction–associated steatotic liver disease (MASLD) in this population remains poorly understood. This systematic review and meta‐analysis assesses the prevalence, cross‐sectional severity, and clinically ...
Michael James +4 more
wiley +1 more source
Role of alcohol in nonalcoholic steatohepatitis: Rush university (Con) patients with nonalcoholic steatohepatitis should be abstinent from alcohol use [PDF]
, 2018 Maham Lodhi, Jaimin Amin, Sheila Eswaran
openalex +1 more source
eFood, Volume 6, Issue 6, December 2025.In light of the steadily increasing incidence of diabetic nephropathy (DN), this review explores the potential of edible natural products to slow disease progression, addressing the limitations of conventional clinical drug therapies. Key findings show that ginsenosides, the active compounds in edible ginseng, regulate lipid autophagy, reducing ...
Rui Zhang +7 more
wiley +1 more source
Vascular adhesion protein 1 in nonalcoholic steatohepatitis: A novel biomarker?
, 2015 Natalie J. Török
openalex +1 more source
Search for novel antifibrotic agents using nonalcoholic steatohepatitis (NASH) organoid model
, 2022 Kiwamu Tanabe +2 more
openalex +2 more sources
A novel S1PR4 functional antagonist prevents nonalcoholic steatohepatitis by deactivating the NLRP3 inflammasome without causing lymphopenia [PDF]
, 2020 Ki‐Up Lee +21 more
openalex +1 more source